liraglutide
Showing 26 - 50 of 523
Obesity, Weight Loss Trial in Beirut (Dietary Intervention Med Diet, Dietary Intervention HP/LC Diet, Dietary Intervention LF
Recruiting
- Obesity
- Weight Loss
- Dietary Intervention Med Diet
- +2 more
-
Beirut, Riad El Solh, LebanonAmerican University of Beirut - Medical Center
Jul 19, 2022
Sleep Apnea, Obstructive Trial in Dublin (drug, device, combination product)
Active, not recruiting
- Sleep Apnea, Obstructive
- Liraglutide (Saxenda) 6Mg/Ml Inj Pen 3Ml
- +2 more
-
Dublin, Dublin 4, IrelandSt Vincent's University Hospital
Jan 28, 2022
Ischemic Stroke, Transient Ischemic Attack, Type 2 Diabetes Trial in Guangzhou (Liraglutide)
Recruiting
- Ischemic Stroke
- +2 more
- Liraglutide
-
Guangzhou, Guangdong, ChinaThe First Affiliated Hospital of Jinan University
Mar 17, 2022
Type2 Diabetes Trial in Charlottesville (Exercise, Liraglutide)
Recruiting
- Type2 Diabetes
- Exercise
- Liraglutide
-
Charlottesville, VirginiaUniversity of Virginia
Mar 7, 2022
Diabetes, Type 2, Hemodialysis, Obese Trial in Paris, Saint-Ouen (Liraglutide)
Recruiting
- Diabetes Mellitus, Type 2
- +2 more
- Liraglutide
-
Paris, Groupe Hospitalier Paris Saint-Joseph, France
- +3 more
Mar 30, 2022
Obesity Trial in New York (Saxenda, Placebo)
Completed
- Obesity
- Saxenda
- Placebo
-
New York, New YorkNew York University Medical Center
Feb 24, 2022
Obesity Trial in Ras al-Khaimah (POSE2.0 Endoscopic Gastric Remodeling, Liraglutide injection)
Recruiting
- Obesity
- POSE2.0 Endoscopic Gastric Remodeling
- Liraglutide injection
-
Ras al-Khaimah, United Arab EmiratesIbrahim Bin Hamad Obaidullah Hospital
Jan 27, 2023
Healthy Trial in Singapore (LY3537021, Liraglutide, Placebo)
Active, not recruiting
- Healthy
- LY3537021
- +2 more
-
Singapore, SingaporeLilly Centre for Clinical Pharmacology
Nov 22, 2022
Type 2 Diabetes Trial in Changchun (Liraglutide injection, Victoza)
Completed
- Type 2 Diabetes
- Liraglutide injection
- Victoza
-
Changchun, Jilin, ChinaAffiliated Hospital of Changchun University of Traditional Chine
Aug 30, 2021
Obesity Trial in Hamburg (GLP-1 (Liraglutide), Placebo)
Terminated
- Obesity
- GLP-1 (Liraglutide)
- Placebo
-
Hamburg, GermanyUniversity Medical Center Hamburg
Jun 29, 2022
Overweight, Obesity Trial in United States (Semaglutide, Placebo (semaglutide), Liraglutide)
Fatty Liver, Nonalcoholic, Diabetes, Type 2 Trial in Alexandria (Metformin)
Active, not recruiting
- Fatty Liver, Nonalcoholic
- Diabetes Mellitus, Type 2
-
Alexandria, EgyptAlexandria University.
Jan 14, 2022
Obesity, Visceral, Cardiovascular Diseases, Fat Disorder Trial in Dallas (Liraglutide, Placebo)
Completed
- Obesity, Visceral
- +2 more
- Liraglutide
- Placebo
-
Dallas, TexasUniversity of Texas Southwestern Medical Center
Oct 20, 2021
Harmonizing RCT-Duplicate Emulations In A Real World Replication
Completed
- Type 2 Diabetes Mellitus
- Canagliflozin
- +4 more
-
Gothenburg, SwedenResearch Site
Oct 23, 2023
Type 2 Diabetes Trial in Miami, Atlanta, New York (Liraglutide + OADs, Glargine + OADs)
Completed
- Type 2 Diabetes
- Liraglutide + OADs
- Glargine + OADs
-
Miami, Florida
- +4 more
Oct 5, 2021
(rPMS) Study of Xultophy® to Evaluate Safety and Effectiveness
Enrolling by invitation
- Diabetes Mellitus, Type 2
- Xultophy® (insulin degludec/liraglutide)
-
Daejeon, Cheongsa-ro, Seo-gu, Korea, Republic of
- +9 more
Mar 21, 2022
Diabetes, Type 2 Treated With Insulin Trial in Bogotá (insulin degludec + liraglutide, Insulin Glargine - Insulin Aspart)
Recruiting
- Diabetes Mellitus, Type 2 Treated With Insulin
- insulin degludec + liraglutide
- Insulin Glargine - Insulin Aspart
-
Bogotá, ColombiaHospital Universitario San Ignacio
Mar 2, 2023
Metabolism and Nutrition Disorder, Obesity Trial in Worldwide (liraglutide, )
Completed
- Metabolism and Nutrition Disorder
- Obesity
- liraglutide
- placebo
-
Santa Monica, California
- +31 more
Nov 18, 2022
Diabetes, Type 1, Type 1 Diabetes Trial in Aalborg (Placebo treatment, Liraglutide treatment)
Completed
- Diabetes Mellitus, Type 1
- Type 1 Diabetes Mellitus
- Placebo treatment
- Liraglutide treatment
-
Aalborg, Jutland, DenmarkMech-Sense, Department of Medical Gastroenterology, Aalborg Univ
Aug 9, 2021
Pre Diabetes, Polycystic Ovary Syndrome, Obesity Android Trial in Baton Rouge (Liraglutide Pen Injector [Saxenda], Placebo
Completed
- Pre Diabetes
- +2 more
- Liraglutide Pen Injector [Saxenda]
- Placebo Liraglutide Pen Injector
-
Baton Rouge, LouisianaWoman's Hospital
Jun 3, 2021
Type 2 Diabetes, Mild Cognitive Impairment Trial in Nanjing (Liraglutide, Empagliflozin, Linagliptin)
Recruiting
- Type 2 Diabetes Mellitus
- Mild Cognitive Impairment
- Liraglutide
- +2 more
-
Nanjing, Jiangsu, China
- +1 more
Mar 28, 2022
Obesity Trial in Changsha (Liraglutide, Liraglutide;metformin)
Withdrawn
- Obesity
- Liraglutide
- Liraglutide;metformin
-
Changsha, Hunan, ChinaXiangya Hospital of Central South University
Apr 8, 2021
Obesity, Obesity, Morbid Trial (Liraglutide Pen Injector)
Withdrawn
- Obesity
- Obesity, Morbid
- Liraglutide Pen Injector
- (no location specified)
Apr 22, 2021